The role of AMPA receptors and their antagonists in status epilepticus

被引:40
|
作者
Leo, Antonio [1 ]
Giovannini, Giada [2 ]
Russo, Emilio [1 ]
Meletti, Stefano [2 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Sci Hlth, Catanzaro, Italy
[2] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy
关键词
AMPA receptors; animal models; glutamate receptors; perampanel; refractory status epilepticus; status epilepticus treatment; REFRACTORY STATUS EPILEPTICUS; INTENSIVE-CARE-UNIT; SYNAPTIC PLASTICITY; GABA(A) RECEPTORS; TREATMENT OPTIONS; RAT HIPPOCAMPUS; NEURONAL DEATH; MESSENGER-RNA; EPILEPSY; PERAMPANEL;
D O I
10.1111/epi.14082
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Status epilepticus (SE) is typically defined as a prolonged self-sustaining seizure or repeated seizures showing an incomplete recovery between them. SE represents a medical emergency often associated with significant disability, morbidity, and mortality. Despite the clinical impact, the mechanisms underlying the transition from self-limited seizures to protracted, medically refractory seizures are not completely understood. About 40% of patients in established SE are refractory to antiepileptic drugs (first-line treatment); therefore, there is a need for more efficacious drugs. In this review, we focused on the current knowledge about the involvement of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors during SE, the preclinical efficacy of its antagonists, and the currently published clinical studies involving drugs with this mechanism of action. We carried out an extensive literature search to recognize experimental and clinical articles both on AMPA receptors and AMPA antagonists and SE. Recently, the role of AMPA receptors during and after SE has become clearer, and it is now widely accepted that early changes occur in the initial stages and probably contribute both to the maintenance of SE and to its refractoriness to treatment. The therapeutic potential of AMPA receptor inhibition has been sustained by studies in which AMPA receptor antagonists have been shown to terminate seizures in several SE animal models. To date, promising, but limited, data in humans support the use of AMPA receptor antagonists in patients with SE. AMPA receptor antagonists could become a new therapeutic option in patients with established SE when the first trials with second-line agents have failed or probably even better after failure of benzodiazepines as a second-line option.
引用
收藏
页码:1098 / 1108
页数:11
相关论文
共 50 条
  • [1] NMDA and AMPA Receptors: Development and Status Epilepticus
    Szczurowska, E.
    Mares, P.
    [J]. PHYSIOLOGICAL RESEARCH, 2013, 62 : S21 - S38
  • [2] The Roles of Glutamate Receptors and Their Antagonists in Status Epilepticus, Refractory Status Epilepticus, and Super-Refractory Status Epilepticus
    Huang, Tzu-Hsin
    Lai, Ming-Chi
    Chen, Yu-Shiue
    Huang, Chin-Wei
    [J]. BIOMEDICINES, 2023, 11 (03)
  • [3] EXPRESSION OF CALCIUM PERMEABLE AMPA RECEPTORS DURING STATUS EPILEPTICUS
    Rajasekaran, Karthik
    Kapur, J.
    [J]. EPILEPSIA, 2009, 50 : 330 - 331
  • [4] EXPRESSION OF CALCIUM PERMEABLE AMPA RECEPTORS DURING STATUS EPILEPTICUS
    Rajasekaran, Karthik
    Kapur, J.
    [J]. EPILEPSIA, 2009, 50 : 311 - 311
  • [5] Calcium-Permeable AMPA Receptors Are Expressed in a Rodent Model of Status Epilepticus
    Rajasekaran, Karthik
    Todorovic, Marko
    Kapur, Jaideep
    [J]. ANNALS OF NEUROLOGY, 2012, 72 (01) : 91 - 102
  • [6] THE PHARMACOLOGY OF AMPA RECEPTORS AND THEIR ANTAGONISTS
    SHEARDOWN, MJ
    [J]. STROKE, 1993, 24 (12) : I146 - I147
  • [7] Receptor trafficking hypothesis revisited: Plasticity of AMPA receptors during established status epilepticus
    Rajasekaran, Karthik
    Joshi, Suchitra
    Kozhemyakin, Maxim
    Todorovic, Marko S.
    Kowalski, Samuel
    Balint, Corinne
    Kapur, Jaideep
    [J]. EPILEPSIA, 2013, 54 : 14 - 16
  • [8] Design of antagonists for NMDA and AMPA receptors
    Bolshakov, KV
    Kim, KH
    Potapjeva, NN
    Gmiro, VE
    Tikhonov, DB
    Usherwood, PNR
    Mellor, IR
    Magazanik, LG
    [J]. NEUROPHARMACOLOGY, 2005, 49 (02) : 144 - 155
  • [9] Pharmacology of AMPA antagonists and their role in neuroprotection
    Gill, R
    Lodge, D
    [J]. NEUROPROTECTIVE AGENTS AND CEREBRAL ISCHAEMIA, 1997, 40 : 197 - 232
  • [10] RAPID CELL-SPECIFIC PLASTICITY OF AMPA RECEPTORS ON THE PRINCIPAL HIPPOCAMPAL NEURONS DURING EXPERIMENTAL STATUS EPILEPTICUS
    Kapur, J.
    Rajasekharan, K.
    [J]. EPILEPSIA, 2011, 52 : 77 - 77